AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology
November 7, 2019sandiegobiotechNewsComments Off on AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology
AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology
/
RSS Feed
Share
Link
Embed
SAN DIEGO–(BUSINESS WIRE)–AvantGen Announces Strategic Collaboration to Develop NK Cell Engager Technology